Search clinical trials for: byl719
Total 74 results
-
Columbia UniversityCompleted
-
Novartis PharmaceuticalsNo longer availableHR+ Advanced or Metastatic Breast Cancer
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsAvailablePIK3CA-Related Overgrowth Spectrum (PROS)
-
Lawson Health Research InstituteActive, not recruitingHead and Neck Squamous Cell CancerCanada
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
Novartis PharmaceuticalsCompletedRelapsed and Refractory Multiple MyelomaItaly, Germany, Singapore, Australia, United States
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingPIK3CA-related Overgrowth Spectrum (PROS)Spain, France, Ireland, United States
-
New Mexico Cancer Care AllianceNo longer available
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
-
Novartis PharmaceuticalsRecruitingLymphatic MalformationsSpain, France, Germany, Australia, United States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedMetastatic or Locally-advanced Unresectable Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Novartis PharmaceuticalsCompletedPre-menopausal Breast Cancer | PI3K Pathway InhibitionTaiwan, Hong Kong, Thailand, Korea, Republic of
-
Centre Hospitalier Universitaire DijonNovartis PharmaceuticalsRecruitingMegalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)France
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Novartis PharmaceuticalsCompleted3rd Line GISTItaly, Belgium, Spain, Netherlands, Germany, United Kingdom, France, United States
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
PfizerCompletedColorectal CancerUnited States, Canada, Australia, Germany, Japan, Netherlands, Spain, France, Belgium, Korea, Republic of, Italy, Norway
-
Murdoch Childrens Research InstituteRoyal Children's Hospital; Peter MacCallum Cancer Centre, AustraliaNot yet recruitingArteriovenous Malformations | Vascular Malformations | MAP2K1 Gene Mutation | PIK3CA-related Overgrowth Spectrum | Vascular Anomalies | Lymphangioma | Lymphatic Malformation | KRAS G12D | Venous Malformation | Vascular Anomaly | KRAS G12C | PI3K Gene Mutation | Slow-Flow Vascular Malformation | Fast-Flow Vascular... and other conditionsAustralia
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedHead and Neck Squamous Cell CancerUnited States
-
University Health Network, TorontoNovartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Locoregionally AdvancedCanada
-
Memorial Sloan Kettering Cancer CenterNovartisCompleted
-
University of ArizonaNational Cancer Institute (NCI)TerminatedHPV Positive Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | CDKN2A-p16 Positive | Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7 | Stage II Oropharyngeal Squamous Cell Carcinoma...United States
-
Kura Oncology, Inc.Recruiting
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
Novartis PharmaceuticalsActive, not recruitingTriple Negative Breast NeoplasmsFrance, Italy, Croatia, Taiwan, Australia, Argentina, Korea, Republic of, China, Israel, Russian Federation, Slovakia, Slovenia, United Kingdom, Germany, Mexico, Switzerland, Spain, Brazil, Hungary, Malaysia, South Africa, Austria, ... and more
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedPIK3CA-Related Overgrowth Spectrum (PROS)Spain, France, Australia, United States, Ireland
-
Novartis PharmaceuticalsCompletedHepatic ImpairmentUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, Breast Neoplasms, Head and Neck NeoplasmsUnited States, Spain, France, Italy
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited Kingdom, France, Australia, Korea, Republic of, Spain, Switzerland, Italy, United States
-
Julie E. Bauman, MD, MPHNovartisWithdrawnOropharyngeal Neoplasms | Oropharyngeal Cancer | Squamous Cell Carcinoma | Carcinoma, Squamous
-
howard safranBrown University; Lifespan; Novartis Pharmaceuticals Corporation (Financial supporter)TerminatedRectal CancerUnited States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Novartis PharmaceuticalsCompleted
-
Baylor College of MedicineRecruitingAcute Ischemic StrokeUnited States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerBelgium, France, China, Italy, Spain, Malaysia, United States, Turkey
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
Pamela MunsterNovartisWithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Solid Tumors, Adult | HPV-Related Squamous Cell Carcinoma | Human Papillomavirus-Related Carcinoma | PIK3CA Mutation-Related Tumors | PIK3CA Mutation | Human Papillomavirus-Related Squamous Cell CarcinomaUnited States
-
Priyanka SharmaNovartis PharmaceuticalsCompletedBreast CancerUnited States
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedPancreatic CancerUnited States